Adverse Effects in the Therapeutic Use of Plasma Substitutes

Explore clinical trials studying Adverse Effects in the Therapeutic Use of Plasma Substitutes. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Adverse Effects in the Therapeutic Use of Plasma Substitutes trial results

Completed

Octaplas Pediatric Plasma Exchange Trial

NCT01938378

Conditions: Adverse Effects in the Therapeutic Use of Plasma Substitutes
Locations: Octapharma Research Site Birmingham, Alabama, United States

Octapharma Research Site Atlanta, Georgia, United States

Octapharma Research Site New Orleans, Louisiana, United States

Octapharma Research Site Minneapolis, Minnesota, United States

View Trial Details

Completed

A Prospective Non-interventional Study to Evaluate the Safety of Methylene Blue Plasma

NCT02007473

Conditions: Adverse Effects in the Therapeutic Use of Plasma Substitutes
Locations: Universitair Ziekenhuis Ghent, Belgium

G. H. A. Evaggelismos Athens, Greece

Complexo Hospitalario Universitario Santiago de Compostela, La Coruña, Spain

University Hospitals of Leicester NHS Trust Leicester, United Kingdom

View Trial Details